Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (460)
Cancellation by sponsor (239)
Cancellation or suspension (79)
Prescription medicine registration (45)
Cancellation for failure to pay annual charge (17)
Australian public assessment report (AusPar) (5)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2026 (6)
2025 (97)
2024 (73)
2023 (99)
2022 (70)
2021 (67)
2020 (112)
2019 (18)
2018 (68)
2017 (104)
2016 (27)
2015 (33)
2014 (13)
2013 (6)
2012 (4)
2011 (6)
2010 (16)
2009 (4)
2008 (3)
2007 (5)
2006 (2)
2005 (2)
2004 (2)
2003 (3)
2002 (2)
2001 (3)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Search

Sponsor content

850 result(s) found, displaying 601 to 610

ATAZANAVIR CIPLA atazanavir 300 mg capsule bottle pack (276193)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATAZANAVIR CIPLA atazanavir 300 mg capsule bottle pack.
ATAZANAVIR CIPLA atazanavir 300 mg capsule blister pack (276192)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATAZANAVIR CIPLA atazanavir 300 mg capsule blister pack.
CIPLA ATAZANAVIR atazanavir 200 mg capsule bottle pack (276203)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA ATAZANAVIR atazanavir 200 mg capsule bottle pack.
CIPLA ATAZANAVIR atazanavir 200 mg capsule blister pack (276202)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA ATAZANAVIR atazanavir 200 mg capsule blister pack.
CIPLA ATAZANAVIR atazanavir 300 mg capsule bottle pack (276205)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA ATAZANAVIR atazanavir 300 mg capsule bottle pack.
CIPLA ATAZANAVIR atazanavir 300 mg capsule blister pack (276204)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA ATAZANAVIR atazanavir 300 mg capsule blister pack.
ZANAVIR CA atazanavir 300 mg capsule bottle pack (276199)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ZANAVIR CA atazanavir 300 mg capsule bottle pack.
ZANAVIR CA atazanavir 300 mg capsule blister pack (276198)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ZANAVIR CA atazanavir 300 mg capsule blister pack.
CIPLA ATAZANAVIR atazanavir 150 mg capsule bottle pack (276201)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA ATAZANAVIR atazanavir 150 mg capsule bottle pack.
CIPLA ATAZANAVIR atazanavir 150 mg capsule blister pack (276200)

30 August 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA ATAZANAVIR atazanavir 150 mg capsule blister pack.

Pages

First page
Previous page
…
Page 57
Page 58
Page 59
Page 60
Current page 61
Page 62
Page 63
Page 64
Page 65
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.